Congress is back in session with a loaded agenda for the lame duck period. One of the top issues the life sciences industry is tracking is the potential passage of the BIOSECURE Act. Speaker Johnson has signaled the House...more
11/20/2024
/ Biotechnology ,
Congressional Committees ,
Grandfathering Rules ,
Healthcare ,
Lame Duck Session ,
Legislative Agendas ,
Life Sciences ,
Pending Legislation ,
Proposed Legislation ,
Senate Committees ,
U.S. House
Donald Trump will be the 47th President of the U.S. Not since 1892 has a President been elected to two non-consecutive terms, and his victory has helped Republicans pick up several critical seats in Congress. Senate...more
11/8/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Department of Health and Human Services (HHS) ,
Donald Trump ,
Election Results ,
Healthcare ,
Healthcare Reform ,
Lame Duck Session ,
Legislative Agendas ,
Members of Congress ,
Presidential Elections ,
Regulatory Agenda ,
Senate Committees ,
Trump Administration
Six months into the fiscal year, Congress has finally passed FY2024 appropriations. It was a painstaking process, which many expected to include policy victories that both sides could celebrate. Instead, the spring work...more
4/9/2024
/ Artificial Intelligence ,
Biotechnology ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicare ,
Mental Health ,
New Legislation ,
Pandemic ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Telehealth ,
Transparency